Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of persoNalized Care After Treatment for Nonmetastasized Breast Cancer Based On Risk of Recurrence, Personal Needs and Risk on (Late) Health Effects: the NABOR Study

NCT05975437 is registered in ClinicalTrials.gov with Comprehensive Cancer Centre The Netherlands as lead sponsor.

NCT NCT05975437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05975437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of persoNalized Care After Treatment for Nonmetastasized Breast Cancer Based On Risk of Recurrence, Personal Needs and Risk on (Late) Health Effects: the NABOR Study
Lead sponsor
Comprehensive Cancer Centre The Netherlands
Phase
Observational
Overall status
Enrolling by invitation
Start date
March 6, 2023
Completion date
March 6, 2027
Enrollment
1,040 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast cancer female, survivorship